L'Oréal announced an increase in its stake in Galderma to 20%, deepening the luxury conglomerate's position in medical aesthetics and dermatology. The move reflects L'Oréal's strategy to integrate prestige skincare with clinical injectables and devices—a convergence play that has defined recent M&A in the space.
Business & M&A
L'Oréal Boosts Galderma Stake to 20% — Strategic Bet on Aesthetics and Skincare Convergence
L'Oréal increased its ownership in Galderma, signaling confidence in the dermatology and aesthetics player despite recent regulatory setbacks.
